Clinical Trial Update: Immunogenicity and Safety PCV-20 of the Vaccine Administered During an Acute Febrile Illness in Adults [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immunogenicity and safety of the PCV-20 pneumococcal vaccine administered during acute febrile illness in adults; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• PCV-20 (20-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Centre Hospitalier Universitaire de Saint Etienne | Conditions: Acute Febrile Illness, Pneumococcal Infections | Phase 4 | Status: RECRUITING